vimarsana.com

Page 20 - வால்டர் நாணல் இராணுவம் நிறுவனம் ஆஃப் ஆராய்ச்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Global Dengue Vaccines Disease Market Analysis Report 2021-2022: Average Probability a Product Advances from Phase III is 68 5%

ResearchAndMarkets.com s offering. The dengue vaccines market is expected to expand rapidly following the anticipated launch of TAK-003 in 2021/22. The pipeline remains active with two late-phase live-attenuated vaccines (LAVs), Takeda s TAK-003 and Merck & Co s TV003/TV005, in development in dengue-endemic regions. TV003/TV005 was initially developed by the US National Institute of Allergy and Infectious Diseases (NIAID) and has been licensed to the Butantan Institute in Brazil, where it is in Phase III trials; Merck & Co in the US, Canada, China, Europe, and Japan; and various other developers in India, the Middle East, and Asia-Pacific markets, with the goal of ensuring market access by facilitating cheaper domestic production in key dengue-endemic regions.

Pioneering animal scientist Van Soest dies at 91

April 19, 2021 Peter Van Soest, professor emeritus of animal science, one of the most influential animal scientists of his generation, died on March 21 in Ithaca. He was 91. Van Soest’s pioneering work permanently changed the chemical and in vitro analysis of feeds and the understanding of herbivore nutrition. His novel and revolutionary methods of analysis created the standard for how researchers measure the nutritional value of ruminating animal forages worldwide. Peter Van Soest “Van Soest was a one-of-a-kind scientist and professor, but he was also a unique individual with a myriad of interests – a modern Renaissance man,” said David Mertens, Ph.D. ’73, president of Mertens Innovation Research LLC and a former graduate student and friend of Van Soest. “His curiosity knew few bounds and he had the passion and intellect to pursue whatever interested him.”

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.